Log in
E-mail
Password
Show password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

RANI THERAPEUTICS HOLDINGS, INC.

(RANI)
  Report
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector news

Rani Therapeutics Holdings, Inc.(NasdaqGM:RANI) added to S&P TMI Index

09/20/2021 | 12:00am EST

Rani Therapeutics Holdings, Inc.(NasdaqGM:RANI) added to S&P TMI Index


ę S&P Capital IQ 2021
All news about RANI THERAPEUTICS HOLDINGS, INC.
11/16RANI THERAPEUTICS : Reports Third Quarter 2021 Financial Results, Provides Corporate Updat..
PU
11/16RANI THERAPEUTICS HOLDINGS, INC. Management's Discussion and Analysis of Financial Con..
AQ
11/15Rani Therapeutics Reports Third Quarter 2021 Financial Results, Provides Corporate Upda..
GL
11/15Rani Therapeutics Reports Third Quarter 2021 Financial Results, Provides Corporate Upda..
GL
11/12RANI THERAPEUTICS HOLDINGS, INC. : Change in Directors or Principal Officers (form 8-K)
AQ
11/12Rani Therapeutics Appoints Lyn Baranowski to Board of Directors
AQ
11/12Rani Therapeutics Holdings, Inc. Appoints Lyn Baranowski to Board of Directors
CI
11/10Rani Therapeutics to Participate in a Fireside Chat at the Stifel 2021 Virtual Healthca..
AQ
09/29RANI THERAPEUTICS HOLDINGS, INC. : Regulation FD Disclosure, Financial Statements and Exhi..
AQ
09/23Rani Therapeutics to Present at Cantor Fitzgerald Virtual Global Healthcare Conference
GL
More news
Analyst Recommendations on RANI THERAPEUTICS HOLDINGS, INC.
More recommendations
Financials (USD)
Sales 2021 2,70 M - -
Net income 2021 -53,0 M - -
Net Debt 2021 - - -
P/E ratio 2021 -17,2x
Yield 2021 -
Capitalization 387 M 387 M -
Capi. / Sales 2021 143x
Capi. / Sales 2022 775x
Nbr of Employees 91
Free-Float 9,27%
Chart RANI THERAPEUTICS HOLDINGS, INC.
Duration : Period :
Rani Therapeutics Holdings, Inc. Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends RANI THERAPEUTICS HOLDINGS, INC.
Short TermMid-TermLong Term
TrendsBearishNeutralNeutral
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus BUY
Number of Analysts 5
Last Close Price 19,65 $
Average target price 28,40 $
Spread / Average Target 44,5%
EPS Revisions
Managers and Directors
Talat Imran Chief Executive Officer & Director
Svai S. Sanford Chief Financial Officer
Mir A. Imran Executive Chairman
Mir Hashim Chief Scientific Officer
Dennis Arthur Ausiello Independent Director
Sector and Competitors
1st jan.Capi. (M$)
RANI THERAPEUTICS HOLDINGS, INC.0.00%463
MODERNA, INC.170.27%114 479
LONZA GROUP AG24.16%58 572
IQVIA HOLDINGS INC.50.86%51 638
SEAGEN INC.-16.39%26 777
CELLTRION, INC.-42.20%23 611